womens' and mens Health Flashcards

1
Q

Risk factors of HPV

A

Early onset of sexual intercourse, multiple sexual partners, HPV infection, tobacco use.

Most cases of cervical CA have occurred with women who have not not been screened in over 5 years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Prevention of HPV infection

A

HPV vaccines, using condoms all the time, Cervical cancer screening (pap smears), not smoking or quitting reduces the risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Risk factors for acquiring cervical CA

A

Almost all cervical CA is caused by HPV.
Having HIV because it makes you immunocompromised.
Smoking.
Using birth control pills for more than 5 yrs
Having multiple partners.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

When should pap smears be performed

A

Start at age 21
Screen every 3 years age 21 to 30
Use cytology only, do not test for HPV
Screen more frequently if high risk, includes women who:
have HIV, (at dx test q 6 months x 2, then annually if wnl)
are immunosuppressed,
were exposed to diethylstilbestrol (DES) in utero, or
have been treated for high grade precancerous cervical lesion or cervical cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Follow up of normal pap or ASCUS based on results of HPV testing

A

High Risk HPV has increased rate progression to cancer in women 30 and over even with normal cytology- recommend test for HPV genotype at age 30 and over*
High Risk HPV = 16 and 18 genotypes
HPV High Risk and NILM (negative for intraepithelial lesion) – refer colposcopy
HPV not High risk – repeat pap & HPV in 12 months
*If unable to do genotyping can repeat in 12 months, if still HPV positive or with ASC or higher refer for colposcopy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Terms of abnormal paps according to the Bethesda system

A

ASC- US Atypical squamous cells of undetermined significance
ASC–H cannot exclude high-grade squamous intraepithelial lesion
LGSIL – low grade
HGSIL – high grade
HGSIL – colposcopy and may need endocervical curetage (ECC) or loop electrosurgical excision (LEEP)
AGC Abnormal or Atypical Glandular Cells
ECC and may need endometrial biopsy and do HPV testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Preconception counseling

A

Medications, OTC meds, herbal remedies
Educate re teratogenic agents: environmental exposures/etoh/drugs
Decrease caffeine to less than 200 mg day
Seafood recommendations …… Shark, king mackerel, tile fish, swordfish (these fish are high in mercury)
Folic acid -400 mcg/day supplements to prevent neural tube defects–
Vitamin D
Weight management – Ideal BMI 19.8 -26.0, exercise
Both under and overweight is concerning
Medical Issues DM, PKU, Asthma, Thyroid, Seizures, SLE, Depression
Labs – rubella/ varicella titres, Hep bSag,, CBC, HIV, STD’s
Detailed 3 generation (or more) Family History
Heritable Disease– refer genetic counseling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Indications for Genetic Counseling

A
Hereditary Disease in family
Maternal age 35 or older
Teratogen exposure
Ethnic background associated with higher risk heritable disease (25 % of genetic background)
Family history of birth defects
Recurrent pregnancy loss
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Screening only if…..

A

The disorder is very debilitating or lethal.
A reliable screening test is available.
The fetus can be treated, or reproductive options (abortion / elective sterilization) are available and acceptable to the parents.
Examples: Hemoglobin electrophoresis to test for sickle cell anemia & the thalassemias, DNA testing for Tay-Sachs disease and cystic fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Family History basics

A

Diseases that occur at an earlier age then expected (10-20 years before most people get the diseases)
Diseases in more than one close relative
Disease that does not usually affect a certain gender (e. g. Breast cancer in male)
Certain combination of diseases within a family (breast and ovarian cancer, or heart disease and diabetes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Prevention of Osteoporosis

Non Pharmacological treatments

A

Adequate Calcium, Vitamin D and regular exercise (weight bearing and muscle strengthening)
Eating foods rich in CA at least 1200mg per day
Vit D 400 to 800 IU per day
Low-fat dairy products
Dark green leafy vegetables
Canned salmon or sardines with bones
Soy products, such as tofu
Calcium-fortified cereals and orange juice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Breast Cancer recommendations

A

USPSTF
Age 50 to 74: Biennial mammograms
Age 40 to 49: Individualized decision re: biennial mammograms
Age 75 and older: Insufficient evidence to make a recommendation re: mammograms
Do not recommend monthly self breast exams (SBE)
Insufficient evidence to recommend clinical breast exams (CBE)
Any risk breast cancer? Start annual mammogram at age 40

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Breast cancer screening

A

Using guidelines individualize discussion
Any risks: start screening age 35 to 40
Age 40 discuss screening options
Continue to offer mammogram screening at age 40, advise re possibility of false positives
Teach SBE and breast awareness???
Do CBE annually?????
High Risk – use guidelines, consider referral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Ovarian Cancer screening

A

No effective screening exists – screening not recommended
Screening has not proven to decrease the death rate from the disease

Use pelvic U/S for adnexal masses
Use CA-125, a tumor marker, for postmenopausal women with an adnexal mass or for detecting relapse
Consider annual trans-vaginal pelvic ultrasound with CA-125 in high risk post menopausal women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Signs and symptoms of depression

A

Rarely is the chief complaint
Often associated with vague somatic complaints and with anxiety
May present with irritability and anger
Feelings of helplessness and hopelessness, Loss of interest in daily activities, Appetite or wt changes
Sleep changes, self loathing, reckless behavior, concentration problems, unexplained aches and pains

No universal screening for depression, but PHQ2 and PHQ9 are useful

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Presentation of MI in women

A

About half of women with an MI present with chest pain.
More likely atypical symptoms: fatigue, sleep disturbance, shortness of breath, back pain, upper abdominal/epigastric pain, nausea with or without vomiting
Less likely to identify their signs and symptoms as those of a heart attack.
Nonchest-pain symptoms may be falsely identified as non-cardiac.
Average delay for treatment: 1 hour longer than men
after being educated about MI symptom presentation, women are more likely to be able to identify atypical MI symptoms.

17
Q

Risk factors of COPD

A

Genes- alpha 1 antitrypsin deficiency
Exposures – tobacco (active and passive)occupational, pollution
Gender - mortality higher in men than women, but over past 20 years dramatic (185%) increase in women
Age
Respiratory infections
Socioeconomic status

18
Q

Definition of COPD

A

Chronic obstructive pulmonary disease (COPD) is a lung disease characterized by chronic obstruction of lung airflow that interferes with normal breathing and is not fully reversible.
The more familiar terms ‘chronic bronchitis’ and ‘emphysema’ are no longer used, but are now included within the COPD diagnosis. COPD is not simply a “smoker’s cough” but an under-diagnosed, life-threatening lung disease

19
Q

Diagnosis of COPD

A

A COPD diagnosis is confirmed by a simple test called spirometry, which measures how deeply a person can breathe and how fast air can move into and out of the lungs.
This diagnosis should be considered in any patient who has symptoms of cough, sputum production, or dyspnea (difficult or labored breathing), and/or a history of exposure to risk factors for the disease.
PFT finding of FEV1/FVC ratio less than 0.70 is diagnostic

20
Q

Prevention of COPD

A

Stop smoking
Quitting smoking slows down the damage to the lungs
Avoid bad air……Air pollution , chemical fumes, dust
Get vaccines—– Flu vax, Pneumococcal, Pertussis

21
Q

Stages of change

A

Pre-contemplation – raise doubts, increase perception of risks
Contemplation – evoke reasons to change, list risks of not changing
Preparation – help patient determine steps to take
Action – help patient take steps toward change
Maintenance – Help pt identify strategies to prevent relapse
Relapse – help pt avoid demoralization, discouragement, get back to action

22
Q

Smoking Cessation, the use of The five “A’s”

Most smokers require multiple attempts before successfully quitting for good. Remind pts of this if they get discouraged in their efforts

A

Ask about tobacco use: Ask the pt at each visit about current tobacco use
Advise to quit through clear personalized messages
Assess willingness to quit: find out the pts thoughts about quitting and if pt is ready to proceed
Assist to quit: Including individual, group, telephone counseling and pharmacological treatment
Arrange follow-up and support

23
Q

Definition and Risk factors for Alcohol Abuse

A

Maladaptive pattern of alcohol abuse, clinically significant impairment or distress with one or more of the following: in the past 12 months:
Failure to fulfill roles at work, school or home
Recurrent alcohol use in hazardous situations
Legal problems related to alcoholism EG DUI
Continued use despite alcohol-related social or interpersonal problems ( fights, relationship losses)

Male gender
Younger age
Single
Lower income
White or Native American
Cumulative exposure to lifetime adverse events
Military combat deployment
Depression, anxiety, antisocial personality
Smoking
Substance abuse
24
Q

Risk factors of ED

A
DM – 50% 
Metabolic syndrome
CVD – htn, chd, lipidemia
Lifestyle – alcohol,  obesity, smoking, sedentary lifestyle (especially in men under 60)
Depression
Neurologic damage
Pelvic or vascular surgery
?BPH
Medications
25
Q

Assessment for ED

A

Ask if high risk
Provider embarrassment = patient embarrassment
Start general, normalize, eg some men with DM (or on such and such a medication) get changes affecting their sex lives, has that happened to you?
Tell me what happens when you want to have sex, changes in libido, erections at other times?

26
Q

AAA screening

A

Prevalence negligible under 60
4 to 6 times more common in men than women
Clinically significant aneurysms (GT 4 cm diameter) in 1 % of men ages 55 to 64, increases by 2 to 4 % each decade
75% of significant aneurysms associated with smoking
Major Risk factors:
Age, male gender, family history, smoking
Other Risk Factors:
Caucasian, Atherosclerosis, PVD, HTN, Aneurysms of femoral or popliteal arteries

27
Q

AAA screening test

A
U/S to assess, recommended fro men 65 to 75 yrs who have ever smoked - 95 to 100 % sensitivity
Specificity of 99 %
Available
Low cost
Safety – no known physical risks
Psychological harm from screening:
Transient anxiety of test, up to 6 weeks
Poorer health perception and anxiety if aaa found not requiring immediate intervention
28
Q

Prostate CA screening

A

Second leading cause of cancer death in American men over 50
Benefits of screening still unproven
Prevalence increases with age, estimated to be present in 100% of men over 80
Lifetime risk of developing prostate cancer is 1 in 6, but risk of death is only 1 in 32
Prostate cancer often so slow growing, most men die of other causes

29
Q

Prostate CA continued

A

Discuss screening, annually, beginning at age 50, to men who have at least a 10-year life expectancy.
Men at high risk (African-American men and men with a strong family of one or more first-degree relatives [father, brothers] diagnosed before age 65) should begin discussion at age 45.
Men at even higher risk, due to multiple first-degree relatives affected at an early age, should begin discussion at age 40.
Informed consent: positive tests will need further invasive testing
Men who ask their PCP to make the decision on their behalf should be advised according to the PCP’s knowledge of their personal risks and health preferences.

30
Q

Anal Cancer

A

Rare
Estimated 5070 cases in US in 2008 – 680 deaths
Rates increasing
Risk factors: HPV infection, multiple sex partners, receptive anal intercourse (esp before age 30), smoking, immunosuppression, HIV, cervical/vulvar cancer,SP pelvic radiation treatment
Limited data on screening

31
Q

Screening and testing

A

Anal pap smear – exfoliative cytology
Avoid anal sex, douching, enemas prior to procedure
Left lateral position
Insert water moistened Dacron swab, until reaches rectal wall, withdraw in spiral motion with lateral pressure
Fix as per pap – Thin Prep or with ethanol
Self collection is an option

32
Q

Testicular cancer screening

A

The USPSTF recommends against screening for testicular cancer in adolescent or adult males.
The sensitivity, specificity, and positive predictive value of testicular examination in asymptomatic patients are unknown. Screening examinations performed by patients or clinicians are unlikely to provide meaningful health benefits because of the low incidence and high survival rate of testicular cancer, even when it is detected at symptomatic stages

33
Q

Osteoporosis screening for Men

A

Screen men over 70
Consider screening younger men at high risk
Guidelines differ –
USPSTF- insufficient evidence
NOF – age 50 if high risk
ACPM – before 65 if high risk, evidence unclear
Screening test is:
Central Bone Density Dual energy x -ray absorbitometry ( DXA)

34
Q

Risk factor for men

A
Low body weight
Hypogonadism
Hyperthyroidism
Previous fractures
Smoking

Check Vitamin D, assess calcium intake, advise weight bearing exercise

35
Q

Changing Behavior

A

Stage of Change

Pre-contemplation

Not currently considering change: “Ignorance is bliss”

Validate lack of readiness

Clarify: decision is theirs

Encourage re-evaluation of current behavior

Encourage self-exploration, not action

Explain and personalize the risk

Contemplation

Ambivalent about change: “Sitting on the fence”

Not considering change within the next month

Validate lack of readiness

Clarify: decision is theirs

Encourage evaluation of pros and cons of behavior change

Identify and promote new, positive outcome expectations

Preparation

Some experience with change and are trying to change: “Testing the waters”

Planning to act within 1month

Identify and assist in problem solving re: obstacles

Help patient identify social support

Verify that patient has underlying skills for behavior change

Encourage small initial steps

Action

Practicing new behavior for

3-6 months

Focus on restructuring cues and social support

Bolster self-efficacy for dealing with obstacles

Combat feelings of loss and reiterate long-term benefits

Maintenance

Continued commitment to sustaining new behavior

Post-6 months to 5 years

Plan for follow-up support

Reinforce internal rewards

Discuss coping with relapse

Relapse

Resumption of old behaviors: “Fall from grace”

Evaluate trigger for relapse

Reassess motivation and barriers

Plan stronger coping strategies